Ibrutinib generic Ibrutinib belongs to a group of medications called as kinase inhibitors. It is prescribed for the treatment of cancer of the cells of the immune system (mantle cell lymphoma) in patients who have been treated earlier with a minimum of one chemotherapy medication. Ibrutinib is also used in the treatment of a cancer that begins in the white blood cells (chronic lymphocytic leukemia) and in the lymph nodes (small lymphocytic lymphoma), and a type of non-Hodgkin’s lymphoma (Waldenström macroglobulinemia). It mainly stops the spread of the cancer cells by blocking the abnormal proteins that signals them to multiply.
More Info about Ibrutinib